作者:
DelVecchio,M. [1]
;
DiGuardo,L. [2]
;
Ascierto,P.A. [3]
;
Grimaldi,A.M. [4]
;
Sileni,V.C. [5]
;
Pigozzo,J. [6]
;
Ferraresi,V. [7]
;
Nuzzo,C. [8]
;
Rinaldi,G. [9]
;
Testori,A. [10]
;
Ferrucci,P.F. [11]
;
Marchetti,P. [12]
;
DeGalitiis,F. ;
Queirolo,P. ;
Tornari,E. ;
Marconcini,R. ;
Calabrò,L. ;
Maio,M.
作者单位:
Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy
[1]
Paolo Giaccone Polyclinic University Hospital, Palermo, Italy
[2]
Melanoma Cancer Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
[3]
Divisione Melanoma e Sarcomi Muscolo-Cutanei, Istituto Europeo di Oncologia IEO-IRCCS, Milan, Italy
[4]
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian, 1
[5]
Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy
[6]
Divisione di Oncologia Medica Del Melanoma, Istituto Europeo di Oncologia IEO-IRCCS, Unità di
[7]
Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione g
[8]
Department of Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano
[9]
Medical Oncology, Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy, Medical Oncology
[10]
University Hospital Pisa, Gathered Hospitals of Santa Chiara, Pisa, Italy
[11]
San Martino Hospital, National Institute for Cancer Research, Genoa, Italy
[12]
发布时间
2014-04-30